Videos
In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie talks about what a low white blood cell count means when it comes to myeloma.
Videos
In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie discusses the important factors one must consider when selecting individualized treatment for myeloma.
Videos
In this episode of #AskDrDurie, Dr. Brian G.M. Durie of the IMF answers a myeloma patient’s question about taking a supplement like vitamin B12 on the same day as Velcade.
Videos
In this episode of #AskDrDurie, Dr. Brian G.M. Durie explores options for myeloma treatment if a patient isn’t receiving a full response from Pomalyst.
Videos
Inspired by last week's #AskDrDurie episode in which Dr. Brian G.M. Durie of the IMF explained the definition of remission when it comes to myeloma patients, this new episode is a follow-up. Here, Dr. Durie explains why a myeloma patient might experience a short remission period, even if high-risk…
Videos
In this week's episode of #AskDrDurie, Dr. Brian G.M. Durie of the IMF answers a patient's question regarding stem cells. If they are harvested in a specific facility, can they be moved and stored elsewhere later?
Find out the answer in this video!
Videos
In this episode of #AskDrDurie, Dr. Brian G.M. Durie talks about the new diagnostic guidelines and tests that can be used to diagnose myeloma early, before CRAB features have emerged. These criteria have been published in a new publication available on myeloma.org.
Videos
In this episode of #AskDrDurie, Dr. Brian G.M. Durie of the IMF answers a patient's question about why the recent FDA ODAC hearing rejected the use of new drug panobinostat for myeloma. He also discusses other HDAC inhibitors that are currently in development.
Videos
In this week's #AskDrDurie, the IMF's Dr. Brian G.M. Durie answers a patient's concern regarding myeloma treatment and heart damage—specifically when it comes to the drug Cytoxan.
Videos
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Stopping to Breathe While Moving Forward!
The benefits of rest, relaxation, exercise, and nutrition
for long -erm…
Videos
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Living Well with Myeloma Teleconference Series:
Chemo Brain - Is it Real?:
What Myeloma Patients and Caregivers…
Videos
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Learn about the latest information regarding a robust immune system’s effects on long-term remission by tuning in to…
Videos
Dr. David Tamborero on the Landscape of Driver Lesions in Multiple Myeloma and Consequences for Targeted Drug Response
Program: Oral and Poster Abstracts
Session: 651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II
David…
Videos
Dr. Elena Zamagni (Seràgnoli Institute of Hematology, Bologna University School of Medicine, Italy) discusses a study investigating the role of FDG PET/CT in smoldering multiple myeloma. In the study, the presence of an FDG PET/CT focal (not osteolytic) lesion or lesions identified a sub-group of…
Videos
Dr. Xavier Leleu (Hopital Claude Huriez, CHRU Lille, France) discusses using Hevylite® to monitor hypogammaglobulinemia, a predictor of response to therapy in multiple myeloma. The results were presented at the 56th American Society of Hematology (ASH) Annual Meeting. ASH 2014 abstract 3383.…
Dr. Roman Hajek: Czech Myeloma Group study on models for progression from MGUS to myeloma (ASH 2014)
Videos
Dr. Roman Hajek (University of Ostrava, Czech Republic) discusses an evaluation of current clinical models for risk of progression from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma or related malignancies in 2,028 people followed in the Czech Republic. These results…
Videos
Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
Stefan Knop, MD
Wuerzburg University Medical Center
Wuerzburg, Germany
Program: Oral and Poster Abstracts
Type: Oral
…
Videos
Dr. Parameswaran N. Hari (Medical College of Wisconsin, Milwaukee) discusses a meta-analysis of pharmacotherapy vs. observation for patients with smoldering multiple myeloma. The results from this meta-analysis were presented at the 56th American Society of Hematology (ASH) Annual Meeting. ASH 2014…
Videos
Interviewed during the 2014 American Society of Hematolog (ASH) meeting, Dr. Benedetto Bruno of the University of Torino in Italy discusses minimal residual disease (MRD) monitoring in myeloma for patients that have had a transplant (Abstract 44).
Prospective Molecular Monitoring of Minimal…
Videos
Jeremy Larsen, MD
Mayo Clinic
Rochester, Minnesota, USA
Free light chain assay and cytogenetic abnormalities for identification of high-risk smoldering myeloma
Abstract No: 8595
Background…
Videos
Gunjan L. Shah, MD
Tufts Medical Center Oncology
Boston Massachusetts, USA
Survival benefit and cost of autologous hematopoietic stem cell transplantation (Auto HSCT) in elderly patients with multiple myeloma (MM) using the SEER-Medicare database
Background: Medicare…
Videos
Keith K. Stewart, MB ChBMayo ClinicScottsdale, Arizona, USAE1A06: A phase III trial comparing melphalan, prednisone, and thalidomide (MPT) versus melphalan, prednisone, and lenalidomide (MPR) in newly diagnosed multiple myeloma (MM)Abstract No: 8511Background: …
ASCO 2014: Continuous treatment versus fixed duration of therapy in newly diagnosed myeloma patients
Videos
Antonio Palumbo, MD
University of Torino
Torino Italy
Continuous treatment (CT) versus fixed duration of therapy (FDT) in newly diagnosed myeloma patients: PFS1, PFS2, OS endpoints
Abstract No: 8515
Background: Continuous therapy significantly…
Audio
Laura and Charlie Mooney are the leaders of the 20-member Staten Island Support Group in New York. The pair became Support Group leaders in 2013, following Charlie’s 2010 myeloma diagnosis.
Audio
Monica and Godfrey Taylor are the leaders of the Kingston, Jamaica Support Group, which they founded with the IMF’s help back in 2013. This pair wanted to establish a Myeloma Support Group to help others living with the disease after Monica’s 2011 myeloma diagnosis.
Audio
Delray Beach, FL
Allan and Gail met on a blind date on a cold wintery December night in 1961. Allan was home from Long Island on a Christmas break from his work at Sperry Gyroscope. They both had attended the University of Pittsburgh, but Allan was three years ahead of Gail, and they had…
Audio
In Memorium: Unfortunately, Elverta Mock Harris passed away on August 13, 2019. She and her late husband Harold shared the story of her myeloma journey here.
Elverta Mock is a Licensed Clinical Social Worker and retired Correctional Administrator.
In 2012, Elverta was diagnosed with myeloma,…
Audio
Doug Young
Ashland, VA
Doug was born in 1948 and diagnosed with multiple myeloma in February 2012. He had stem cell transplant at VCU in 2013 and retired from UPS shortly after. Prior to that he worked as V.P. of Operations for a trucking company and as college professor at Liberty University.…
Videos
In this week's video, Dr. Brian Durie answers the question regarding statins and its effect on myeloma patients.Bottom Line:Myeloma patients need to be cautious when taking statins...But not overly concerned about their impact on the myeloma itself.
Audio
Jack and Linda Huguelet are the leaders of the Chattanooga, Tennessee Support Group. They have been leading the 10-member group since 2011, following Linda’s 2010 myeloma diagnosis.
Audio
Jim Shoemaker was diagnosed with myeloma in 2007. In 2013, he and his wife Linda began their leadership of the Memphis, Tennessee support group. Together they lead a group averaging anywhere from 12 to 20 members.
Audio
Joe and Sandy Brown became active members of the myeloma community after Sandy’s myeloma diagnosis 25 years ago. Together they’ve been involved in the Atlanta, Georgia Support Group for more than 15 years and have been co-leaders of the nearly 40-member group since 2011. Sandy is also on the Group…
News Article
This was a busy week in the world of cancer research!
Amgen announced promising follow-up results from the ASPIRE trial in which KRd (Kyprolis®, Revlimid® and dexamethasone) has produced a median overall survival of 48.3 months versus Rd’s 40.4 months for patients in the first relapse…
News Article
THOUSAND OAKS, Calif. (July 24, 2015) – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Kyprolis® (carfilzomib) for Injection in combination with Revlimid® (lenalidomide) and dexamethasone (KRd) for the…
Videos
In this week's video Dr. Brian G.M. Durie answers Laura Mooney's question about amyloidosis and if myeloma patients should be screened for it.
Bottom Line:
Keep amyloidosis testing on your doctor's checklist.
News Article
NORTH HOLLYWOOD, Calif., July 22, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today announced publication of a new updated edition of Multiple Myeloma: A Textbook…
Videos
In this week's video, Dr. Brian G.M.Durie answers a question if the symptoms of Vitamin B12 deficiency is an effect of multiple myeloma treatment.
BOTTOM LINE:
Look for other issues that could be causing symptoms that might be easily corrected…
Videos
In this week's video, Dr. Brian G.M. Durie answers a question on how common toxoplasmosis is and how multiple myeloma patients can protect themselves.
News Article
WASHINGTON, D.C. June 12, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – applauds the introduction today of legislation by Senators Al Franken (D-MN) and Mark Kirk (R-IL),…
Videos
In this week's video, Dr. Brian G.M. Durie discusses the practical details of Fluorescence In Situ Hybridization (FISH) testing.
News Article
The International Myeloma Foundation (IMF) presented the 14th annual Robert A. Kyle Lifetime Achievement Award to Dr. S. Vincent Rajkumar during a ceremony in Copenhagen, Denmark on Wednesday evening, June 8, 2016. The award was given during the IMF’s annual …
News Article
The International Myeloma Foundation (IMF) and Xian-Janssen (XJP) cooperate in a program of joint activities to strengthen the capacity of Chinese hematologists working in the field of myeloma.
As part of this cooperation, IMF briefing sessions featuring internationally renowned…
News Article
North Hollywood, CA, June 3, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – will host the 6th Annual International Myeloma Working Group (IMWG) Summit June 8-10 in Vienna,…
Videos
In this week's video, Dr. Brian G.M. Durie answers the question "Are veterans with myeloma a unique population?" Dr. Durie also talked about the challenges that veterans face to get the best care available to them. For more information about veterans with myeloma you can visit: www.veterans.myeloma…
Videos
In this week's video, Dr. Brian G.M. Durie discusses how does myeloma affect the immune system and what can be done for the immune system to work better.
Videos
In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how intravenous immunoglobulin is being used as a treatment option for multiple myeloma.
Videos
In this episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses the risks that can come with chiropractic care for patients with myeloma. He also offers some alternative therapeutic options for those who need them.
News Article
Los Angeles, CA - (April 29, 2015) - It is with great sadness that the International Myeloma Foundation (IMF) announces the death of Michael S. Katz, a longtime member of its Board of Directors.
"We are deeply saddened by the passing of Mike Katz," said Susie Novis, IMF…
Audio
When Katherine Morgan was diagnosed with myeloma in 2008, her biggest concern was if she would be able to continue with her life as she knew it. Photography was her passion, and she was also concerned about being around her beautiful children and grandchildren, who always have runny noses, etc…